Last year, Intelligence Squared U.S. and the Mayo Clinic brought to
the stage a bold inquiry about whether health care in the United States
is terminally broken. And this year, we’re picking up where that
discussion left off, against the backdrop of corporate behemoths
announcing mergers that, they say, are sure to shake up health care –
from the Amazon, Berkshire Hathaway, and JPMorgan Chase venture, to the
CVS-Aetna deal, to the Humana-Walgreens partnership, and more. But while
these superpower alliances are making a splash in the headlines, will
they actually be able to disrupt, and save, U.S. health care? Proponents
argue that the bargaining power and data competencies of these
retailers will squeeze middlemen out of an inefficient supply chain and
bring more transparency to health care pricing. But others argue that
the promise of these novel efforts is overstated or misguided,
particularly because U.S. health care is so complex and deeply rooted.
Will consumer-focused models and employer-led initiatives lead to better
and less expensive outcomes?
Source.
No comments:
Post a Comment